Relenza (zanamivir), a new INHALED antiviral to reduce flu symptoms

This flu season, Glaxo will market Relenza (zanamivir), a new INHALED antiviral to reduce flu symptoms. ...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote